Patents by Inventor Fabienne Piras-Douce

Fabienne Piras-Douce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human Cytomegalovirus Immunogenic Composition
    Publication number: 20230277655
    Abstract: The invention relates to an immunogenic composition comprising an HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen and a TH1-inducing adjuvant. It further relates to the immunogenic composition for use as an HCMV vaccine.
    Type: Application
    Filed: December 8, 2022
    Publication date: September 7, 2023
    Inventors: Pascal Chaux, Rafaela Dumas, Jean Haensler, Sylvie Pichon, Fabienne Piras-Douce
  • Human cytomegalovirus immunogenic composition
    Patent number: 11524069
    Abstract: The invention relates to an immunogenic composition comprising an HCMV gB antigen, an HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen and a Th1-inducing adjuvant. If further relates to the immunogenic composition for use as an HCMV vaccine.
    Type: Grant
    Filed: September 11, 2018
    Date of Patent: December 13, 2022
    Assignee: Sanofi Pasteur
    Inventors: Pascal Chaux, Rafaela Dumas, Jean Haensler, Sylvie Pichon, Fabienne Piras-Douce
  • Human cytomegalovirus immunogenic composition
    Patent number: 11207403
    Abstract: The invention relates to an immunogenic composition comprising an HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen and a TH1-inducing adjuvant. It further relates to the immunogenic composition for use as an HCMV vaccine.
    Type: Grant
    Filed: October 15, 2020
    Date of Patent: December 28, 2021
    Assignee: Sanofi Pasteur
    Inventors: Pascal Chaux, Rafaela Dumas, Jean Haensler, Sylvie Pichon, Fabienne Piras-Douce
  • Human Cytomegalovirus Immunogenic Composition
    Publication number: 20210023202
    Abstract: The invention relates to an immunogenic composition comprising an HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen and a TH1-inducing adjuvant. It further relates to the immunogenic composition for use as an HCMV vaccine.
    Type: Application
    Filed: October 15, 2020
    Publication date: January 28, 2021
    Inventors: Pascal Chaux, Rafaela Dumas, Jean Haensler, Sylvie Pichon, Fabienne Piras-Douce
  • Human Cytomegalovirus Immunogenic Composition
    Publication number: 20200276301
    Abstract: The invention relates to an immunogenic composition comprising an HCMV gB antigen, an HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen and a Th1-inducing adjuvant. If further relates to the immunogenic composition for use as an HCMV vaccine.
    Type: Application
    Filed: September 11, 2018
    Publication date: September 3, 2020
    Inventors: Pascal Chaux, Rafaela Dumas, Jean Haensler, Sylvie Pichon, Fabienne Piras-Douce